IPCA Laboratories

IPCA Laboratories Inventory Turnover

The Inventory Turnover Ratio of IPCA Laboratories (IPCALAB.NS) as of Nov 16, 2026 is 1.09. In the previous year, Inventory Turnover Ratio was 1.30 — a change of -15.96% (lower).

Inventory Turnover

1.09

YoY

-15.96%

Last updated:

Inventory Turnover Ratio of IPCA Laboratories is 2026 1.09 . Inventory Turnover Ratio of IPCA Laboratories was 2025 1.30 . It decreases by -15.96% lower compared to the previous year.

The IPCA Laboratories Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2019
1.39 INR
Jan 1, 2020
1.47 INR
Jan 1, 2021
1.28 INR
Jan 1, 2022
1.28 INR
Jan 1, 2023
1.57 INR
Jan 1, 2024
1.24 INR
Jan 1, 2025
1.30 INR
Jan 1, 2026
1.09 INR
The IPCA Laboratories Inventory Turnover history
YEARInventory TurnoverYoY
1.09-15.96%
1.30+5.13%
1.24-21.17%
1.57+22.25%
1.28+0.49%
1.28-13.01%
1.47+5.22%
1.39-10.04%
1.55-0.34%
1.55+1.30%
1.53+11.51%
1.38-18.39%
1.69—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IPCA Laboratories Stock analysis

What does IPCA Laboratories do? Ipca Laboratories Ltd. generates revenue through the manufacturing and marketing of over 350 pharmaceutical formulations and approximately 80 active pharmaceutical ingredients (APIs), including Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts, and Propranolol. The company sells its branded products such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, and Venpower in more than 100 countries globally. Its subsidiaries, Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd, and Tonira Exports Limited, support the distribution and sales of these products across international markets. The company's primary customers are healthcare providers, hospitals, and pharmacies in over 100 countries, purchasing both generic APIs and branded formulations. Manufacturing units in India produce APIs and formulations, with the firm's subsidiaries facilitating global market access. The therapeutic segments covered by its products include cardiovascular, antimalarial, and gastrointestinal treatments, among others, driven by the demand for cost-effective pharmaceutical solutions. IPCA Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IPCA Laboratories stock

Inventory Turnover Ratio of IPCA Laboratories is 1.09 in 2026.

Inventory Turnover Ratio of IPCA Laboratories changed from 1.30 to 1.09, representing a -15.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio IPCA Laboratories since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's IPCA Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — IPCA Laboratories

All Key Metrics — IPCA Laboratories